Skip to content

Mindfulness Training for Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Mindful Parenting

Mindfulness Training for Children With ADHD and Mindful Parenting

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03220308
Acronym
MindChamp
Enrollment
103
Registered
2017-07-18
Start date
2016-02-18
Completion date
2019-02-22
Last updated
2019-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit Hyperactivity Disorder

Keywords

Self-control, Well-being

Brief summary

This study evaluates the effectiveness of an 8-week mindfulness group training for children (8-16 years old) with ADHD in combination with a parallel mindful parenting training for their parents. Half of the participants will be randomly assigned to the mindfulness training in addition to care-as-usual (CAU); the other half to CAU-only. The hypothesis is that compared to care-as-usual only, the addition of the mindfulness training will improve self-control of youth with ADHD.

Interventions

OTHERMYmind mindfulness training

The MYmind mindfulness training uses a standardised protocol based on mindfulness-based cognitive therapy. It consists of 8 weekly group sessions of 90 minutes for youth with ADHD, and parallel mindful parenting training for the parents. Eight weeks after the last session there is a single 90 minutes booster session.

OTHERCare-as-usual for children (8-16 years old) with ADHD

According to the Dutch Multidisciplinary guidelines for the diagnosis and treatment of ADHD, care-as-usual for children aged 8-16 years with ADHD consists of psycho-education and the prescription of medication approved for ADHD and/or evidence-based parent and/or teacher-administered behaviour therapy, preferably both medication and behaviour therapy. First-line option for medication is a psychostimulant, second-line option is atomoxetine, and third-line options are alpha-2 presynaptic agonists or tricyclic antidepressants (imipramine).

Sponsors

Radboud University Medical Center
CollaboratorOTHER
Fonds Psychische Gezondheid
CollaboratorOTHER
European Commission
CollaboratorOTHER
UvA minds
CollaboratorUNKNOWN
University of Amsterdam
CollaboratorOTHER
Karakter Kinder- en Jeugdpsychiatrie
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* Child has a clinical diagnosis of ADHD according to the Diagnostic and Statistical Manual of Mental Disorders; DSM-IV or DSM-5 system, and confirmed by a structured interview (The Schedule for Affective Disorders and Schizophrenia for school-Age Children (K-SADS)). * Child receives CAU and has remaining ADHD-symptoms (average score \> 1.0 on the investigator-rated DSM-5 items from the Conners' ADHD rating scale). * Child is between 8 and 16 years old. * At least one parent is willing to participate. * ADHD medication dose is stable, or there is an informed decision on not taking ADHD medication. * Psychiatric comorbidities are allowed except psychosis, bipolar illness, active suicidality, untreated posttraumatic stress disorder or substance use, provided ADHD is the primary diagnosis in the child; similarly, psychopathology in the parents is allowed except psychosis, bipolar disorder, active suicidality, untreated posttraumatic stress disorder or substance use. * Child and parent have an estimated intelligence quotient (IQ) ≥ 80. * Child and parent have adequate mastery of Dutch language.

Exclusion criteria

* Child or the participating parent(s) have participated in a mindfulness programme in the past year or ever in a Mindful Parenting training. * Child or parent is participating in another intervention study.

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline in parent-rated self-control of the childBaseline, 3, 5 and 9 monthsBehaviour Rating Inventory of Executive Function, parent-report (BRIEF-P)

Secondary

MeasureTime frameDescription
Change from Baseline in parent-rated autistic social impairment of the childBaseline, 3 and 9 monthsSocial Responsiveness Scale, parent-report (SRS-P)
Change from Baseline in parent-rated quality of life of the childBaseline, 3 and 9 monthsKIDSCREEN-10, parent-report
Change from Baseline in teacher-rated self-control of the childBaseline, 3 and 5 monthsBehaviour Rating Inventory of Executive Function, teacher-report (BRIEF-T)
Change from Baseline in teacher-rated behaviour problems of the childBaseline, 3 and 5 monthsConners' Teacher Rating Scales-Revised: Long (CTRS-R), subscales: inattentive and hyperactive-impulsive symptoms according to the 4th version of the Diagnostic and Statistical Manual (DSM-IV), oppositional, anxious/shy, social problems and the Emotional Lability index
Change from Baseline in teacher-rated autistic social impairment of the childBaseline and 3 monthsSocial Responsiveness Scale, teacher-report (SRS-T)
Change from Baseline in self-rated dispositional mindfulness of the childBaseline, 3, 5 and 9 monthsChild and Adolescent Mindfulness Measure (CAMM), self-report
Change from Baseline in self-rated brooding of the childBaseline, 3 and 9 monthsRuminative Response Scale (RRS), subscale: brooding, self-report
Change from Baseline on the Stop task in the childBaseline, 3 and 9 monthsComputer based neurocognitive assessments of self-control in the child
Change from Baseline on the Probabilistic reversal learning task in the childBaseline, 3 and 9 monthsComputer based neurocognitive assessments of self-control in the child
Change from Baseline on the Temporal discounting task in the childBaseline, 3 and 9 monthsComputer based neurocognitive assessments of self-control in the child
Change from Baseline in parent-rated behaviour problems of the childBaseline, 3, 5 and 9 monthsConners' Parent Rating Scales-Revised: Long (CPRS-R), subscales: inattentive and hyperactive-impulsive symptoms according to the 4th version of the Diagnostic and Statistical Manual (DSM-IV), oppositional, anxious/shy, social problems and the Emotional Lability index
Change from Baseline in self-rated ADHD traits of the parentBaseline, 3, 5 and 9 monthsDSM-5 based ADHD traits, self-report
Change from Baseline in self-rated mindfulness in parenting of the parentBaseline, 3, 5 and 9 monthsInterpersonal Mindfulness in Parenting Scale (IM-P), self-report
Change from Baseline in self-rated autistic traits of the parentBaseline, 3 and 9 monthsShort Autism Quotient Questionnaire-Adult Version (AQ-10), self-report
Change from Baseline in self-rated symptoms of depression, anxiety and stress in the parentBaseline, 3 and 9 monthsDepression Anxiety Stress Scale-21 (DASS-21), self-report
Change from Baseline in self-rated emotional well-being, psychological well-being and social well-being of the parentBaseline, 3 and 9 monthsMental Health Continuum-Short Form (MHC-SF), self-report
Change from Baseline in self-rated quality of life of the parentBaseline, 3 and 9 monthsWorld Health Organization-Five Well-Being Index (WHO-5), self-report
Change from Baseline in self-rated brooding of the parentBaseline, 3 and 9 monthsRuminative Response Scale (RRS), subscale: brooding, self-report
Change from Baseline on the Stop task in the parentBaseline, 3 and 9 monthsComputer based neurocognitive assessments of self-control in the parent
Change from Baseline on the Probabilistic reversal learning task in the parentBaseline, 3 and 9 monthsComputer based neurocognitive assessments of self-control in the parent
Change from Baseline on the Temporal discounting task in the parentBaseline, 3 and 9 monthsComputer based neurocognitive assessments of self-control in the parent
Change from Baseline in self-rated self-control of the parentBaseline, 3, 5 and 9 monthsBehaviour Rating Inventory of Executive Function, self-report (BRIEF-A)

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026